Affimed NV (AFMD)
5.44
+0.10
(+1.87%)
USD |
NASDAQ |
May 16, 16:00
5.44
0.00 (0.00%)
After-Hours: 20:00
Affimed Research and Development Expense (Quarterly): 20.09M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.09M |
| September 30, 2023 | 23.41M |
| June 30, 2023 | 27.56M |
| March 31, 2023 | 31.72M |
| December 31, 2022 | 34.24M |
| September 30, 2022 | 26.32M |
| June 30, 2022 | 22.19M |
| March 31, 2022 | 20.62M |
| December 31, 2021 | 31.64M |
| September 30, 2021 | 24.31M |
| June 30, 2021 | 26.27M |
| March 31, 2021 | 13.74M |
| December 31, 2020 | 19.96M |
| September 30, 2020 | 11.81M |
| June 30, 2020 | 12.88M |
| March 31, 2020 | 12.63M |
| December 31, 2019 | 13.88M |
| September 30, 2019 | 13.03M |
| June 30, 2019 | 12.97M |
| March 31, 2019 | 9.073M |
| December 31, 2018 | 13.48M |
| September 30, 2018 | 11.38M |
| Date | Value |
|---|---|
| June 30, 2018 | 8.536M |
| March 31, 2018 | 7.857M |
| December 31, 2017 | 5.426M |
| September 30, 2017 | 7.063M |
| June 30, 2017 | 5.976M |
| March 31, 2017 | 5.797M |
| December 31, 2016 | 6.175M |
| September 30, 2016 | 9.777M |
| June 30, 2016 | 9.748M |
| March 31, 2016 | 7.797M |
| December 31, 2015 | 7.696M |
| September 30, 2015 | 7.166M |
| June 30, 2015 | 6.194M |
| March 31, 2015 | 3.296M |
| December 31, 2014 | 5.154M |
| September 30, 2014 | 2.890M |
| June 30, 2014 | -2.824M |
| March 31, 2014 | 7.324M |
| December 31, 2013 | 7.407M |
| September 30, 2013 | 3.698M |
| June 30, 2013 | 5.521M |
| March 31, 2013 | 2.503M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
11.81M
Minimum
Sep 2020
34.24M
Maximum
Dec 2022
21.01M
Average
20.62M
Median
Mar 2022
Research and Development Expense (Quarterly) Benchmarks
| InflaRx NV | 7.931M |
| MorphoSys AG | 86.49M |
| BioNTech SE | 551.24M |
| Immatics NV | 34.88M |
| CureVac NV | 35.93M |